HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87 | +13.0% | 750 | 0.0% | 0.03% | +6.9% |
| Q2 2023 | $77 | -6.1% | 750 | 0.0% | 0.03% | -3.3% |
| Q1 2023 | $82 | -3.5% | 750 | 0.0% | 0.03% | -11.8% |
| Q4 2022 | $85 | -99.8% | 750 | 0.0% | 0.03% | +54.5% |
| Q3 2022 | $46,000 | -23.3% | 750 | 0.0% | 0.02% | -15.4% |
| Q2 2022 | $60,000 | -24.1% | 750 | 0.0% | 0.03% | -10.3% |
| Q1 2022 | $79,000 | -2.5% | 750 | 0.0% | 0.03% | +3.6% |
| Q4 2021 | $81,000 | -1.2% | 750 | 0.0% | 0.03% | -12.5% |
| Q3 2021 | $82,000 | +17.1% | 750 | 0.0% | 0.03% | +14.3% |
| Q2 2021 | $70,000 | +1.4% | 750 | 0.0% | 0.03% | -20.0% |
| Q1 2021 | $69,000 | +25.5% | 750 | 0.0% | 0.04% | +20.7% |
| Q4 2020 | $55,000 | +41.0% | 750 | +50.0% | 0.03% | +26.1% |
| Q3 2020 | $39,000 | +39.3% | 500 | 0.0% | 0.02% | +27.8% |
| Q2 2020 | $28,000 | -87.4% | 500 | -93.3% | 0.02% | -90.9% |
| Q1 2020 | $222,000 | -18.4% | 7,500 | 0.0% | 0.20% | -2.0% |
| Q4 2019 | $272,000 | +33.3% | 7,500 | 0.0% | 0.20% | +29.5% |
| Q3 2019 | $204,000 | +13.3% | 7,500 | 0.0% | 0.16% | +8.3% |
| Q2 2019 | $180,000 | – | 7,500 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |